| 摘要 |
The present invention relates to polysaccharides selected from sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans intended to be used as a drug for the preventive or curative treatment of an influenza virus, as well as to the pharmaceutical compositions including, in particular in combination with at least one pharmaceutically acceptable carrier: either an extract of Codium fragile, including sulphated arabinogalactans, or an extract of Zostera marina or Lemna minor, including apiogalacturonans, or an extract of Caulerpa racemosa, including sulphated heteroglycans. |
| 申请人 |
ELICITYL;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE;COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIESALTERNATIVES |
发明人 |
LINA, BRUNO;FERRARIS, OLIVIER;VO, HO HONG HAI;COSSET, FRANÇOIS-LOÏC;SZECSI, JUDIT;HEYRAUD, ALAIN;LORTAT-JACOB, HUGUES;BARTOLI, JULIA;SADIR, RABIA;LIVACHE, THIERRY;DARBLADE, BENOÎT;HAVET, STÉPHANE;BONNET, SILVÈRE |
